Drug
Aro Alk7
Aro Alk7: highest development phase Phase 1/2, developed by Arrowhead Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arrowhead Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARO-ALK7 NCT06937203 | Phase 1/2 | Obesity |
Latest
No recent events.
Follow Aro Alk7 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.